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INTRODUCTION: Kidney transplantation corrects endocrine imbalances. Nevertheless, these early favorable events
are not always followed by rapid normalization of parathyroid hormone secretion. A possible deleterious effect of
parathyroidectomy on kidney transplant function has been reported. This study aimed to compare acute and long-
term renal changes after total parathyroidectomy with those occurring after general surgery.
MATERIALS AND METHODS: This was a retrospective case-controlled study. Nineteen patients with persistent
hyperparathyroidism underwent parathyroidectomy due to hypercalcemia. The control group included 19 patients
undergoing various general and urological operations.
RESULTS: In the parathyroidectomy group, a significant increase in serum creatinine from 1.58 to 2.29 mg/dl (P ,
0.05) was noted within the first 5 days after parathyroidectomy. In the control group, a statistically insignificant
increase in serum creatinine from 1.49 to 1.65 mg/dl occurred over the same time period. The long-term mean serum
creatinine level was not statistically different from baseline either in the parathyroidectomy group (final follow-up
creatinine=1.91 mg/dL) or in the non-parathyroidectomy group (final follow-up creatinine=1.72 mg/dL).
CONCLUSION: Although renal function deteriorates in the acute period following parathyroidectomy, long-term
stabilization occurs, with renal function similar to both preoperative function and to a control group of kidney-
transplanted patients who underwent other general surgical operations by the final follow up.
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INTRODUCTION
Secondary hyperparathyroidism (HPT) is an almost
universal complication in patients with chronic renal failure.
Successful kidney transplantation corrects endocrine and
metabolic imbalances and the main abnormalities respon-
sible for secondary HPT in the first months following
surgery.
1 Nevertheless, these early favorable events are not
always followed by a rapid normalization of parathyroid
hormone (PTH) secretion. Elevated PTH levels are observed
in up to 25% of patients one year after transplantation,
despite adequate renal function.
2 A subgroup of these
patients will ultimately require parathyroidectomy.
A possible deleterious effect of parathyroidectomy on
kidney transplant function was reported.
3 Evidence of
an acute effect of parathyroidectomy without significant
compromise in the long run was reported.
4 In one study, the
only parameter observed to correlate with an acute decrease
in renal function was an acute reduction in PTH.
5
In one study of successfully kidney-transplanted indivi-
duals, renal changes after total parathyroidectomy with
immediate autograft, which were estimated by variation in
creatinine level, differed in comparison to changes in kidney
transplant patients undergoing other head and neck proce-
dures.
6 In that study, the control group included only a
small number of patients, and observation was restricted to
the first days after the operation. These aspects limit the
conclusions that can be drawn regarding the long-term
safety of total parathyroidectomy in the management of
persistent HPT after kidney transplantation. Although
kidney dysfunction has also been described in patients
undergoing subtotal parathyroidectomy,
7 one study sug-
gested the superiority of this technique over total parathyr-
oidectomy with autotransplantation in the management of
persistent HPT after kidney transplantation.
8 For some renal
transplant patients, it was recommended that total para-
thyroidectomy should be avoided to avoid compromising
long-term renal function.
8
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431The present study aimed to compare acute and long-term
renal changes in patients undergoing either total parathyr-
oidectomy and immediate autotransplantation or compar-
able general surgical operations in a larger subset of kidney
transplant patients.
METHODS
The study was a retrospective case-controlled study of
renal allograft recipients at a single institution. This study
was part of a project approved by the Institutional Ethical
Committee on research. Records from all patients who
received a kidney transplant at the University of Sa ˜o Paulo,
Hospital das Clinicas, between January 2000 and December
2006 were reviewed. A total of 905 patients were analyzed
which may be compared to the 715 patients who received
kidney transplants in the five year period 2002-2007 covered
by the official registry of the Institution.
9 Kidney transplant
patients who underwent a total parathyroidectomy with
autotransplantation for persistent HPT or for HPT devel-
oped after transplantation were designated the case group.
The control (non-parathyroidectomy) group consisted of
renal transplant cases submitted to elective abdominal
operations. Figure 1 shows patient selection. The following
subjects were excluded from the final analysis: patients with
infected abdominal surgeries and patients who received
their parathyroid or abdominal surgeries at other centers.
The demographic data, cause of renal failure, type of
renal pre-transplant replacement therapy, type of donor,
immunosuppressive therapy, dialysis duration before trans-
plantation, time from transplantation to surgery, serum
creatinine levels and estimated creatinine clearance were
analyzed. Creatinine clearance was estimated using the
Cockroft-Gault equation. Creatinine levels were compared
at baseline (i.e., before the operation), in the early post-
operative period (i.e., the highest value obtained during the
first week after the operation) and in the long-term follow
up. All patients were followed until the first occurrence of
renal transplant failure (defined as the need for renal
replacement therapy or preemptive renal retransplantation),
death or 1 January of 2007 (end of study).
Statistical analyses for continuous variables are presented
as mean ¡ standard deviation in cases in which the
distribution is parametric. Student’s t test was employed to
verify possible differences between groups. Contingency
tables were created for qualitative variables and were tested
by Fisher’s Exact Test or the chi-square test, as appropriate.
RESULTS
Between January 2000 and December 2006, 28 of 905 renal
transplant patients at our transplant outpatient clinic
underwent parathyroidectomy because of persisting hyper-
parathyroidism, resulting in a period prevalence of 3.1%.
Nine patients were excluded from the evaluation because
they underwent parathyroidectomy at other centers. During
the same period, 62 patients underwent abdominal surgery.
Of those, 26 had non-elective operations, and procedures
took place in other centers; these were excluded from the
present analysis.
The 19 patients with persistent HPT underwent parathyr-
oidectomy due to hypercalcemia. The 19 patients in the
control group received general and urological operations as
follows: herniorrhaphy in 9, radical prostatectomy in 4,
transurethral prostatectomy in 2, 1 cholecystectomy, 1
laparoscopic nephrectomy, 1 open nephrectomy plus chole-
cystectomy and 1 open herniorrhaphy plus cholecystectomy.
Renal replacement therapy before transplantation consisted
of hemodialysis in 95% of the parathyroidectomy group and
89% ofthecontrol group. None ofthecases in the study group
underwent peritoneal dialysis before transplantation as
compared with 5% of the control group. The remaining
patients in both groups had pre-emptive renal transplanta-
tion, with no significant differences in mean time on dialysis
or mean time of surgery after renal transplantation. The mean
time on dialysis before renal transplantation was 86.1 (range
0-204) months in the parathyroidectomy group and 57.2
(range 0-120) months in the control group (p=0.047). The
mean time for surgery after renal transplantation was 34
months(range7–69months)fortheparathyroidectomy group
and 26.9 months (range 3-76) for the control group (p=0.23).
The cause of chronic renal failure was glomerulonephritis
or vasculitis in 47% of the patients undergoing parathyr-
oidectomy and in 37% of the controls. Hypertensive disease
induced renal failure in 26% of the study cases and in 21% of
the controls. Cystic, hereditary or congenital diseases were
Figure 1 - Patient Selection (PTX = Parathyroidectomy).
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432found in 11% of the cases and in 21% of the controls.
Diabetes was not observed in any of the study cases but was
present in 5% of the controls. The etiology of renal failure
was unknown or missing in 11% of the patients who
underwent parathyroidectomy. The donated kidney was
from a deceased donor in 84% of the cases in both groups.
Immunosuppression was similar in both groups. Table 1
shows the mean age, gender, type of immunosuppressant,
duration of dialysis before transplantation, time of surgery
after transplantation, mean preoperative creatinine and
preoperative estimated glomerular filtration rate for
patients in the two groups.
In the parathyroidectomy group, the mean PTH was
350 pg/mL (range 134-3950) and the mean total calcium
was 10.7 mg/dL (range 10.2-12.7). There were no operative
deaths. A significant increase in serum creatinine from1.58 to
2.29 mg/dL (p,0.05) was noted in the parathyroidectomy
group within the first 5 days after parathyroidectomy. An
insignificant increase in serum creatinine occurred
in the control group in the first 5 days after surgery (baseline:
1.49mg/dL; day 5: 1.65mg/dL). On the fifth day after
surgery, creatinine was higher in the parathyroidectomy
group (p,0.05) than in the control group.
In the parathyroidectomy group, renal function stabilized
after 24 ¡ 10 months of follow up. At that time, the mean
serum creatinine value (1.91 mg/dL) was not statistically
different from baseline. Renal function stabilized after 31 ¡
24 months in the non-parathyroidectomy group, with a final
follow-up creatinine mean value of 1.72 mg/dL (Figure 2).
At the long-term follow up, one death related to sepsis
had occurred in the parathyroidectomy group, and two
deaths related to cardiovascular disease had occurred in the
non-parathyroidectomy group. None of the deaths were
related to the surgical procedures. Censoring for death
revealed similar findings. In the group of patients who
underwent parathyroidectomy after the kidney transplanta-
tion, only two patients lost the graft, with one at 22 months
post-surgery and the other at 63 months. The three patients
were diagnosed with chronic allograft nephropathy. None
of the controls lost their kidney grafts. The difference in
graft loss was not statistically significant (p=0.48).
DISCUSSION
The decision to recommend parathyroid surgery after
kidney transplantation is a difficult one. Evidence-based
Table 1 - Demographic and clinical data.
PTX Group (n =19) NON-PTX Group (n=19) P
Age (years) 44.7¡10.7 48.5¡12.3 0.20
Sex Male (%) 36% 67% 0.10
IMMUNOSUPPRESSION Steroids 100% 100% 1.0
Cyclosporin A 58% 74% 0.49
Tacrolimus 41% 21% 0.29
Azathioprin 21% 32% 0.71
Mycophenolate mofetil or Sodium 79% 68% 0.71
Rapamycin 0% 5% 1.0
Duration of dialysis before transplantation (months) 86.1 (0-204) 57.2 (0-120) 0.047
Time after transplantation (months) 36 (7-69) 28 (3-76) 0.23
Creatinine before surgery (mg/dL) 1.58 ¡ 0.6 1.49 ¡ 0.6 0.65
Creatinine clearance (Cokcroft-Gault) (mL/minute) 48.6 44.6 0.9
Legend: PTX= parathyroidectomy; NON-PTX= other operations.
Figure 2 - Renal Function before surgery, after surgery and at the last follow up.
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433guidelines are currently lacking, and thus, laboratory data,
clinical symptoms and imaging data should all be con-
sidered. A previous report suggested a possible deleterious
effect of total parathyroidectomy with immediate auto-
transplantation on long-term kidney graft survival.
8
Although the present study demonstrated an acute dete-
rioration of renal function in the acute period after
parathyroidectomy, renal function was similar to baseline
and the control group at the final follow up. This suggests
that the deterioration only persists short term. Group that
contained patients undergoing some urological surgeries
with a greater interference in renal function, the difference
observed in the first week remained unchanged.
The present paper clearly shows that acute changes in
renal function are not the same after parathyroidectomy and
other comparable operations not involving the parathyroid
glands, leading one to consider anesthetic or post-trauma
effects on these variables.
10 Indeed, one study demonstrated
that renal function after total parathyroidectomy without
immediate autotransplantation did not differ even from that
of patients undergoing subtotal parathyroidectomy.
11 This
study emphasizes that persistent HPT is an important
surgical disease in kidney transplant patients, as parathyr-
oidectomy accounted for approximately 31% (28 of 90) of all
operative diseases of these patients. Cinacalcet may play an
effective role in the clinical management of such patients
12,
but the drug is not yet available for patients in Brazil.
The results presented here demonstrate that parathyroi-
dectomy, which is an important therapeutic modality for
kidney transplant patients, appears to be safe for kidney
function irrespective of the technique employed. Notwith-
standing, determining the mechanism involved in the acute
deterioration of renal function that occurs shortly after
parathyroidectomy may permit better patient selection and
determination of the most appropriate type of parathyr-
oidectomy in kidney-transplanted patients.
13
Acute renal changes after parathyroidectomy are also
seen in some patients undergoing parathyroidectomy for
primary HPT. In the past, these alterations were clinically
evidenced by the presence of oliguria, but it is now possible
to observe a significant elevation in creatinine shortly after
the surgery.
14 Clinically evident renal failure may occur
even in more recent cases.
15,16
Much has been said in the literature about the hemody-
namic effects of PTH on the kidney,
17-19 but precise
mechanisms for long-term alterations in renal function have
not been proposed. Moreover, contradictory information
has been presented.
4 In 1983, Pang et al. suggested that
different segments of the PTH molecule might have specific
activities.
20 It seems reasonable to speculate that the variable
patterns of creatinine change after parathyroidectomy may
result from the activity of another parathyroid substance or
of a PTH fragment.
PTH-related protein (PTHrP) is an autocrine/paracrine
peptide expressed in renal tubules and vasculature that may
play an important role in regulating overall renal function. It
was first identified as a tumor-derived protein responsible
for humoral hypercalcemia of malignancy.
21 PTHrP is
homologous to PTH in the N-terminal region, suggesting a
possible basis for the similarity of this peptide’s actions to
those of PTH when secreted into the systemic circulation by
malignant tumors. Experimental analysis has shown that
PTHrP can act as an endogenous vasorelaxant, modulating
renal responses to vasoactive stimuli.
16 This effect suggests
the possibility that calcineurin inhibitors, which act as
powerful glomerular vasoconstrictors, might worsen creati-
nine levels.
22 In any case, both the acute and chronic effects of
high levels of PTH on kidney function deserve further study,
as apparently contradictory results have been described.
23,24
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